Watch out Tesaro, AstraZeneca and Merck get FDA OK for broad use of Lynparza
AstraZeneca and its new Big Pharma partner Merck have picked up the FDA’s approval for the broad use of Lynparza, which will put …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
